DNA Harvesting via PCR tests?

  • Updated:11 months ago
  • Reading Time:23Minutes
  • Post Words:6269Words
Print Friendly, PDF & Email

Post to take notes on the potential DNA harvesting.

Another one that has been in my drafts way too long that I’m just going to post because the information is infinite and might take years to uncover.

Living Document. First published 18 June 2022 | Last Updated: 24 Sept 2022

Feb 17, 2022 - CDC admits it collected DNA with PCR-test

On Feb 17, 2022, the CDC posted the above tweetRemember that #COVID19 nose swab test you took? What happened to the swab? If it was processed with a PCR test, there’s a 10% chance that it ended up in a lab for genomic sequencing analysis.” with a video linkHow Nose Swabs Detect New Covid-19 Strains” – both of which caused people all over the world to go nuts.

The next day they posted a new tweet “… our tweet led to some confusion. To clarify: CDC and our partners conduct genome sequencing analysis of the virus that causes COVID-19. Sequencing of the virus helps identify and monitor the spread and impact of variants. ” with a link to their website.

And all the people that don’t know how corrupt the CDC is, believed them.

PCR-Test Inappropriate for Detecting COVID

  • RT-PCR was only meant to be used on selected patients with a high “index of suspicion.”
  • A false-positive occurs when someone is tested for SARS-CoV-2 (COVID-19) and returns a positive test but is actually virus free. (01)
  • They are normal but the test says they are not. (02)

Jan 25, 2020 - COVID PCR-Test Instructions Fraudulent

The paper recommending the PCR test for detection of COVID had been submitted on January 22 and published the very next day.

10 Fatal Flaws in the original Corman-Drosten paper (07) (08) (09)

2020 - High Case Numbers because of instructions and WHO fraudulent guidelines

Positive reverse transcription polymerase chain reaction (RT-PCR) tests are not designed to be used as a diagnostic tool as they cannot distinguish between inactive (noninfectious) viruses and “live” or reproductive ones (10)

Once that paper was accepted by WHO, they said when the test is positive, we have a “case” of COVID-19. And this is how they started counting the cases. What they counted was the activity of testing. And the more they tested, the more cases they found. (11) (12) (13) (14) (15) (16)

Inactive and reproductive viruses are not interchangeable in terms of infectivity. If you have a nonreproductive virus in your body, you will not get sick from it and you cannot spread it to others. Further, many if not most laboratories amplify the RNA collected far too many times, which results in healthy people testing “positive.”

The PCR test only tests for certain sequences of the RNA. It gives a positive result when it only finds a small fragment; it doesn’t need the whole virus. If the virus was there weeks ago or you have a touch of the virus present, but no infection, it can still test positive and add another COVID-19 “case,” even though you’re not actually sick.

Furthermore, the RT-PCR was never meant for asymptomatic testing

  • RT-PCR was only meant be used on selected patients with a high “index of suspicion”.
    • Nevertheless it has been rolled out essentially as a population screen.

False Positives, the Common Cold, & PCR Reagents

COVID-19 testing may cross-react with the common cold, influenza or other pneumonia’s

  • This is a very valid concern.
  • The test kits use things called primers and probes.
  • These are designed by the manufacturer to attach to parts of the target virus (SARS-CoV-2).
  • Many different primers/probes could be used to get the job done.
  • Many are essentially a mirror image of an interval or portion of the target section of RNA to be identified.
  • You do NOT want to choose primers/probes which also attach and identify other viruses (such as the common cold of which 15% are coronaviruses).
  • Obviously if this happens you’ll be identifying the WRONG virus and will be getting a false-positive result.
  • So choosing the right primer/probe is CRITICAL to prevent cross-reactivity and identify the CORRECT virus.

False-positives can occur due to:

  • :i) Collection from the wrong patient -mislabelling
  • ii) Transcription mistakes -wrong result/data entry by the Lab Scientist
  • iii) Incorrect interpretation of the results by the Lab Scientist
  • iv) Contamination of primary specimen
  • v) Contamination of reagents in the kit by amplicon (piece of RNA used in testing process)vi) Contamination by control standard
  • vii) Self-priming by amplification of non-specific PCR products from multiple cycling above the Cycling threshold (Ct)
  • viii) Non-target genetic material cross-reactivity

Choosing the right primer/probe is critical to prevent cross-reactivity and identify the correct virus. https://www.ncbi.nlm.nih.gov/guide/howto/design-pcr-primers/

CDC-designed PCR Tests detect Human Genetic Material

All CDC PCR test primers and probes are common in human DNA and microbes (17) (18)

All genetic sequences used in the widely-used CDC PCR test are commonly found in human and microbial DNA, which is likely generating significant numbers of false positive test results; the degree to which false positives are being generated due to this serious design flaw is an empirical matter that requires additional research.

  • All three of CDC’s original test probes were parts of the virus’s N gene (the probes were labeled N1, N2 and N3).
  • A BLAST search function to look for all of the primers and probes used in the CDC test, which is a total of 9 sequences in the test as approved (N1, N2 and RNase P) found all primers and probes are commonly found in human DNA and microbial genetic material, in sequence lengths far longer than the 10 bases required for a probe to bind. (19)

Beijing Genomics Institute (BGI)

Beijing Genomics Institute (BGI) is a Chinese company that specialises in making test kits for DNA collection. At the start of the pandemic, they offered their supplies of PCR-Testing kits. These kits are reported to be some of the most unreliable in the world.

BGI has been building this database in Wuhan:

  • BGI has been accused of being an arm of the CCP and building a Genetic database of Western Populations as well as non-Han ethnic Populations.
  • This is ostensibly for genetic offensive weapons programs.
  • BGI test kits were banned from California by the CIA as they were deemed a security threat.
  • Not even the United States of America has selected these kits.

The Australian Strategic Policy Institute (ASPI) has reported is a National Security Threat:

BGI use their own Proprietary PCR reagents

BGI use their own Proprietary PCR reagents for the testing kits:

  • BGI Proprietary platforms/machines/reagents supplied to “read” the results.
  • These testing kits use RT-PCR technology. (Reverse Transcriptase -Polymerase Chain Reaction) testing kits.
    • Contract tracing of false-positive people creates more testing and more false-positives.
    • RT-PCR was NEVER intended to be a population screening test.

Choosing the right primer/probe is critical to prevent cross-reactivity and identify the correct virus.

So which primers/probes are being used by the Beijing Genomics Institute (BGI) in their Victorian test kits? We don’t know:

  • It has not been disclosed.
  • It is a secret.

How could CCP create a False-Pandemic to cause economic harm, panic, fear, misdiagnosis, wrong medical treatments, etc.?

  • Being completely in control of false-positives.
  • A false-positive occurs when someone is tested for SARS-CoV-2 (COVID-19) and returns a positive test but is actually virus free.
    • They are normal or have something else, but the test says they are “COVID-positive”.
  • False-positives are measured by the Specificity of the tests.
    • TEST TEST TEST creates never ending false-positives even IF the virus has actually disappeared
    • Contract tracing of false-positive people creates more testing and more false-positives.

2010 - China invests 1.5 Billion in BGI for Individualized DNA = Control Healthcare

“The future of medicine has to do with individualized DNA – massive amounts of bio-data so we can predict our diseases before we even get them – and whoever has that information is going to control health care in the world and China knows that, so BGI group is the biggest of these companies. It had 1.5 billion dollars in funding from the Chinese government in 2010.”

Aug 2020 - BGI PCR used in Sweden

  • Thousands of Swedes had received false-positives by August 2020, using the same tests.

May 2020 - BGI PCR used in Victoria, Australia

Beijing Genomics Institute (BGI) is the Chinese company chosen to provide test kits to Victoria. https://bgi-australia.com.au/covid-19-updates-1 (20) (21) (22)

  • The BGI testing kits were flown into Tullamarine Airport (Melbourne) on Chinese Airlines for delivery to Private Pathology Practices in Victoria.
  • They have been brought in batches, at intervals, since mid-May 2020 -just before the Victorian outbreak began.

BGI as a National Security Threat:

  • No other state in Australia has obtained their kits from this company but instead rejected them.
  • ASIO/ASIS (pure Deep State organisations) have allowed BGI to operate unhindered in Australia.

BGI was given fast-track approval:

The Victorian government did not tender for the test kits from anywhere else including Australian suppliers, thus not giving any other company the opportunity.

  • The TGA (Therapeutic Goods Administration) made a special legal exemption to grant BGI fast-track access to the Australian market.
  • The Doherty Institute approved the kits by way of fast tracking approval.
  • The Health Minister or CHO or Premier or all of them at the time approved these kits despite objection by the relevant body,

Even though we had our own kits:

  • PTA (Pathology Technology Australia) filed an audit stating there was “more than enough technology in the field”. (23)
    • Capacity to ramp up production existed
  • No tenders were made and the decision was to EXCLUDE Australian companies.
    • No transparent reasons were given. (24)

2018-2021 - Dan Andrews is a China Puppet

Dan Andrews Ties to China

  • Daniel Andrews defends his controversial Belt and Road deal with China – May 2020 (26)
    • “The Victorian government has stood firm on its controversial multi-billion dollar deal with China, despite its relationship with Australia continuing to sour.”
    • “As the issue became further marred in controversy on Wednesday, the state’s premier Daniel Andrews defended his handling of the fractious trade deal. “
    • “He has been heavily criticised for signing Beijing’s $1.5 trillion Belt and Road infrastructure deal, all without the approval of the federal government.”
  • Inside Victoria’s controversial Belt and Road Initiative deal with China – April 2021 (27)
    • On a seemingly ordinary October morning in 2018, senior officials from the Department of Foreign Affairs and Trade were blindsided in a pretty spectacular way. A newspaper article about a historic deal between Victoria and China saw a flurry of confused panic ripple through the government’s frontline force for all things global affairs.
    • Premier Daniel Andrews had signed a memorandum of understanding with Beijing to make his state a member of the Communist Party’s $1.5 trillion Belt and Road Initiative – the only government in the country to do so.
    • In fact, it came after the Commonwealth had declined an invitation to sign on, largely out of concerns about China’s true intentions, so the news was viewed as quite astounding to DFAT. A key player in “Team Australia” had gone rogue and they’d just found out about it at the same time as everybody else.
  • USA News show calls Dan Andrews China’s Puppet (28)

June 26, 2020 - Minderoo | Gates | Zuckerberg | Wellcome 'Global Sharing of COVID Data'

Gates, Minderoo, Zuckerberg, Wellcome & Mastercard create a COVID hub to collaborate the global COVID-19 data. (29)

“Scientists across the globe can share their data on a new digital platform, pooling their knowledge, discoveries and skills to fast track vital treatments for COVID-19.

The alliance co-founders and major donors include Australia’s Minderoo Foundation, the Bill and Melinda Gates Foundation, Chan Zuckerberg Initiative, Mastercard and Wellcome.

The international consortium hopes the workbench will break down research silos that stymie progress and open access to emerging data to accelerate the development of therapies for COVID-19.

Professor Steve Webb, chairman of the global COVID-19 clinical trial REMAP-CAP, said the data-sharing platform was groundbreaking, solving a problem in science research that predates the pandemic.

Dr Steven Kern, deputy director of quantitative sciences at the Bill and Melinda Gates Foundation said the workbench would allow researchers to access data that could validate, redirect or build on their own work.

The platform is designed to be useful long after pandemic abates to develop therapies for future pandemics and the global fight against other diseases such as cancers.”

April 2020 - Minderoo ties to China BGI Test Kits

Minderoo ties to China

  • BGI was sourced by Minderoo, an Australian company with a history of dealings with China procuring 10 million of these kits in April 2020 at a cost of $189 ($US136) million.
    • Mindaroo got an extra $320 million from the Australian Government for procurement.

So MINDEROO procured 10 million test kits from BGI in April:

  • How on earth did they know Victoria wouldn’t need them?
    • Only 500,000 were required by May in all of Australia.
  • This particular deal made massive profits for BGI -all paid for by Australian taxpayers.
  • The BGI testing kits were flown into Tullamarine Airport (Melbourne) on Chinese Airlines for delivery to Private Pathology Practices in Victoria.
  • They have been brought in batches, at intervals, since mid-May -just before the Victorian outbreak began.

BLAST is a database of the genetic sequences of pathogens held by the NCBI (National Center for Biotechnology Information).

Jan 29, 2020 - Doherty Institute, Melbourne Covid & BGI Shenanigans

The Doherty Institute in Melbourne, Victoria has done a post-market validation study of the BGI kits. (35)

  • Importantly this study was done on select BGI kits in April 2020 before the mass importation of kits in mid-May 2020.
    • What did the study find?
    • It found a difference in Specificity (with some as low as 97.5% -even excluding pre-analytical errors) between batches (lots) of the BGL kits.
    • You would think this would be a Red Flag!
      • Nope -they recommended the BGL kits saying it was within parameters.
    • No explanation was given for the poor Specificity of certain (batches) lots but I assume they thought it was due to reagent amplicons.
    • Importantly; they have not done ANY more QUALITY CONTROL studies on the new mass batches of test kits/reagents which BGI has supplied since May!
    • Unbelievable!
    • No more QUALITY CONTROL of BGI against Gold Standard Australian Control tests!

The Doherty report was submitted by:

  1. Mr Thomas Tran
    • Senior Scientist of Virus Identification Laboratory
  2. Ms Gina Papadakis – (Georgina Papadakis)
    • Lab Team of Virus Identification Laboratory (no other information found other than a group lab photo on the Doherty website)
  3. Ms Charlene Mackenzie –
    1. Medial Lab Scientist – that only joined VIDRL in April 2020 (straight out of uni into being one of the named authors on the BGI pandemic-testing report… can’t make this up really.)
  4. Dr Julian Druce
    • Head of Virus Identification Laboratory (Head of above 3)
    • His work practices span Biosafety levels 2, 3 and 4 and he operates laboratories at all these levels. His laboratory is designated as one of three World Health Organization (WHO) National Influenza Centre (NIC) laboratories, a WHO Regional Measles Reference Laboratory, and houses the National High Security Quarantine Laboratory (NHSQL) for diagnosis of high level pathogens causing viral haemorrhagic fever.
  5. Dr Mike Catton
    • Associate Director of Partnerships, former Deputy Director of the Doherty Institute, He and VIDRL senior scientist Julian Druce gained international attention in January 2020 for culturing the SARS COV-2 virus and for immediately sharing the virus internationally. Under his leadership, VIDRL supported initial development of SARS-COV-2 testing capacity around Australia and in near-neighbour countries, and was Victoria’s reference laboratory for SARS-COV-2 through the pandemic. Mike has led many major infectious diseases outbreak investigations over the years including SARS-COV-1, avian influenza, pandemic influenza, Zika virus, and Ebola virus. He played a leading role in the creation of the Doherty Institute into which VIDRL relocated in April 2014.

Dr Julian Druce & Dr Mike Catton were the first in the world to apparently grow the virus.

Jul 23, 2022 - DNA bioweapons & weaponized food (AspenSecurity Forum)

DNA bioweapons & weaponized food #AspenSecurity

A national security panel regarding biological weapons that can target DNA and weaponized food from the Aspen Strategy Group and Aspen Security Forum.

23 July 2022: Clip (Rumble | Telegram) | Full Livestream (YouTube)

See expanded post about this (38)

Feb 12, 2022 - President Macron refused Russia's PCR (DNA fears)

French President Emmanuel Macron refused Russia’s PCR test because “we could not accept that they get their hands on the president’s DNA”

Jul 19, 2017 - US Air Force seeks Tissue RNA Samples from Caucasian Russians

Links for validation:

  • GovTribe Federal Contract Opportunity: Synovial Tissue / RNA Samples.
    • Added: Jul 19, 2017 4:26 pm
    • Q2: Would you consider samples from Ukraine?
    • A2: No, all samples (Synovial tissue and RNA samples) shall be collected from Russia and must be Caucasian. The Government will not consider tissue samples from Ukraine.
    • Federal Contract Website | Archive | US Air Force Archive

  • Pentagon Biolaboratories – Investigative Documentary
  • Military interest: the US Air Force wants to purchase living tissue samples from Russians
    • July 28, 2017
    • “The Air Training Command of the US Air Force has published a contract for the purchase of RNA samples – living tissues of Caucasian Russians. The corresponding tender is posted on the US government procurement website. The potential supplier, when making the samples available to the Air Training Command, must also provide information on the health status of the donors. The military department needs samples of RNA molecules that are involved in the implementation of human genetic information, and synovial fluid that provides joint mobility. RT asked experts for what purpose the US military intends to make such purchases.”
    • The US Air Force plans to purchase 12 samples of RNA molecules (contained in all living cells and necessary for the translation of genetic information into proteins) and 27 samples of synovial fluid (an important component of the joint that ensures its mobility) from Russian donors. This is stated in the US Air Force contract, which was posted on the portal of government tenders on July 19.
    • “All fresh frozen synovial tissue and RNA samples must come from normal donors without musculoskeletal injury. Samples of synovial tissue and RNA may not match each other, that is, come from different donors. All synovial tissue and RNA samples must come from people who test negative for HIV, hepatitis B, hepatitis C and syphilis,” the contract says.
    • “At the time of delivery, the contractor must provide a sample identity card, indicate gender, age, nationality, diagnosis, date of surgery, date of diagnosis, symptoms, smoking history, medications taken, height, weight,” the contract says.
    • Samples must be delivered to the Lekland Air Force Base (San Antonio, Texas) within ten days after the contractor receives the money.
    • When asked by RT regarding the purpose of the purchase, the curator of the contract, Markus Mattingly, did not provide an operational comment.
    • The American medical clinic ProteoGenex, which is located in Culver City (California), became interested in the tender. The organization’s website says that it specializes in collecting human tissue, including RNA, which is extracted from the blood of a donor. It is also noted that ProteoGenex has 200,000 different biomaterial samples at its disposal.
    • At the same time, military expert and former member of the UN biological weapons commission Igor Nikulin noted that RNA samples can be used to develop viruses.
    • “New types of biological weapons are being developed. It cannot be in the military department for anything else. Most likely, these could be combat viruses. The United States is trying to develop various types of biological weapons specifically for specific carriers of the gene pool, and Caucasians are needed, since they make up the majority of the population of our country. This is the same focus group they are trying to pick up the keys to. It is necessary that viruses act selectively – on certain national groups. This task was partially solved by the American program “Human Genome“. It was also largely funded by the Pentagon, ”the expert expressed the point of view.
    • Russian RT Website

  • Russian genetic material is being harvested all over the country, purposefully and professionally,
    • Oct 31, 2017
    • Putin clarified that the material is collected on different ethnic groups and in different regions. “The question is, why are they doing this? They do it professionally and purposefully. We are such an object of very great interest,”

Jun 4, 2015 - George Soros Funds Ukraine Lab

  • George Soros funding Ukraine Lab (page 3)

Jan 28, 2022 - PCR tests used to track variants

Scientists from around the world are using nose swabs to track the emergence of SARS-CoV-2 variants. Here’s how it works.

Wired-YouTube | Jan 28, 2022

Jun 15, 2018 - DNA Weapons | Dr Charles Morgan | Psycho-Neurobiology & War | Key Points

DNA Weapons | Dr Charles Morgan | Psycho-Neurobiology & War | Key Points

15 Jun 2018 Dr. Charles Morgan speaks to cadets and faculty at West Point about a range of topics, including psychology, neurobiology, and the science of humans at war. Dr. Morgan’s neurobiological and forensic research has established him as an international expert in post-traumatic stress disorder, eyewitness memory, and human performance under conditions of high stress.

The event was organized and hosted by the Modern War Institute at West Point.

See expanded post about this (40)

Jul 28, 2018 - 23andMe $300 million deal with GlaxoSmithKline

Big Pharma Would Like Your DNA23andMe’s $300 million deal with GlaxoSmithKline is just the tip of the iceberg. (41)

23andMe board member said to Fast Company in 2013. “Once you have the data, [the company] does actually become the Google of personalized health care.

So this week’s announcement that GlaxoSmithKline is investing $300 million in 23andMe and using the DNA company’s de-identified, aggregate customer data for drug research is very much in keeping with the long-term business plan. You don’t make that kind of money selling $99 spit kits.

23andMe customers can opt of out their data being used in research, but the vast majority of its 5 million customers have opted in.

The deal comes at a time as pharmaceutical companies are increasingly looking to DNA for new drug ideas. In 2015, 23andMe announced its first partnership with a pharmaceutical company—in which it would study Parkinson’s with Genentech. The deal was reportedly just the first of ten at the time, according to Forbes. 23andMe has also since published studies with scientists from Pfizer, Janssen, and GlaxoSmithKline.

Elsewhere in the world, the Icelandic biopharmaceutical company deCODE has sequenced over half of Iceland’s adult population to identify genes associated with diseases. deCODE was acquired by Amgen and then the Chinese pharmaceutical company WuXi in 2015. A consortium of six big drug companies—AbbVie, Alnylam, AstraZeneca, Biogen, Pfizer, and Regeneron—are paying to sequence all the genes from 500,000 participants in the U.K. Biobank, in exchange for exclusive access to the data for 12 months. (23andMe uses a technique called genotyping to spot-check 600,000 locations in the genome, but it does also entirely sequence the genes.) Regeneron also partnered with Pennsylvania’s Geisinger Health System to sequence 250,000 of its patients.

Jan 8, 2018 - Pfizer, AstraZeneca, GlaxoSmithKline etc genetic exome sequence data UK Biobank

January 8, 2018 Regeneron Forms Consortium Of Leading Life Sciences Companies To Accelerate Largest Widely-Available ‘Big Data’ Human Sequencing Resource With Uk Biobank (42)

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), along with new collaborators AbbVie, Alnylam Pharmaceuticals, AstraZeneca, Biogen and Pfizer Inc., today announced the formation of a major ‘pre-competitive’ consortium to fund the generation of genetic exome sequence data from the 500,000 volunteer participants who make up the UK Biobank health resource. The newly announced collaborators will each commit $10 million to enable a dramatic acceleration of sequencing timelines, and additional companies are considering joining the consortium. Regeneron will conduct the sequencing effort. The sequencing data will be paired with detailed, de-identified medical and health records within the UK Biobank resource, including enhanced measures such as brain, heart and body imaging, to create an unparalleled resource for linking human genetic variations to human biology and disease.

It was originally planned that sequencing of all 500,000 samples in the UK Biobank would be completed by 2022, with the first 50,000 people sequenced during 2017 with funding from Regeneron and GlaxoSmithKline. Now, by engaging several leading Life Sciences companies to form this new consortium, it will be possible to complete the exome sequencing of all 500,000 participants by the end of 2019, with all data made broadly available by UK Biobank to researchers by the end of 2020. This consortium effort thus greatly accelerates delivery to the global scientific community of the largest ‘big data’ resource linking human sequence data to other health-related information. Sequencing of UK Biobank’s samples will continue to be performed at the Regeneron Genetics Center (RGC) facility, one of the world’s largest and most sophisticated human genetics sequencing centers.


Penny... on Health
Penny... on Health

Truth-seeker, ever-questioning, ever-learning, ever-researching, ever delving further and deeper, ever trying to 'figure it out'. This site is a legacy of sorts, a place to collect thoughts, notes, book summaries, & random points of interests.

DISCLAIMER: The information on this website is not medical science or medical advice. I do not have any medical training aside from my own research and interest in this area. The information I publish is not intended to diagnose, treat, cure or prevent any disease, disorder, pain, injury, deformity, or physical or mental condition. I just report my own results, understanding & research.